This review summarizes the evidence base for routine and emerging pharmacological therapies for acute cardiogenic pulmonary edema in the emergency department.
Offers clinicians a synthesis of ED pharmacotherapy for acute cardiogenic pulmonary edema; leaves open optimal use of emerging agents pending prospective trials.
This paper critically reviews the major drug types that are currently used in the management of acute cardiogenic pulmonary oedema. As decompensated heart failure becomes an increasingly common problem in emergency departments in the developed world, optimization of emergency drug therapy for these critically ill patients is essential. The evidence base for 'routine therapy' in the ED is considered. The review also briefly considers emerging pharmacological therapies that may have an impact on future management of cardiogenic pulmonary oedema.
No takes yet. Share an insight, caveat, or question.
Colin A. Graham (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: